Literature DB >> 23443318

Conservative management for an entero-adnexal fistula at initial presentation of advanced ovarian carcinoma.

A Shai1, E Grikshtas, Y Segev, M Moskovitz, A Bitterman, M Steiner, O Lavie.   

Abstract

Gastrointestinal fistulae can occur in ovarian cancer patients, usually in the setting of advanced relapsed disease. Treatment typically involves immediate surgery.Here, we describe a case of an abscess resulting from an intestinal fistula as the first manifestation of advanced epithelial ovarian cancer, and we review the current literature on this subject. The patient was successfully treated with a combination of chemotherapy, antibiotics, and delayed surgery. Optimal debulking was achieved without a need for bowel resection.This report is the first of conservative management of a fistula in an ovarian cancer patient in the chemotherapy-naïve setting.

Entities:  

Keywords:  Fistula; abscess; chemotherapy; ovarian cancer; serous

Year:  2013        PMID: 23443318      PMCID: PMC3557342          DOI: 10.3747/co.20.1196

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  16 in total

1.  A giant gas-filled abdominal mass in an elderly female: a case report.

Authors:  Hoi Man Deon Chong; Fung Yee Janet Lee; Anthony Lo; Chak Man Jimmy Li
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

2.  Perforation of a malignant ovarian tumor into the recto-sigmoid colon.

Authors:  Anne-Sophie Bats; Andrea G Rockall; Naveena Singh; Rodney H Reznek; Arjun Jeyarajah
Journal:  Acta Obstet Gynecol Scand       Date:  2010-10       Impact factor: 3.636

3.  Benign cystic ovarian teratoma with a fistula into the small and large bowel.

Authors:  Astrid R von-Walter; Rebecca S Nelken
Journal:  Obstet Gynecol       Date:  2012-02       Impact factor: 7.661

4.  A phase 3 trial of bevacizumab in ovarian cancer.

Authors:  Timothy J Perren; Ann Marie Swart; Jacobus Pfisterer; Jonathan A Ledermann; Eric Pujade-Lauraine; Gunnar Kristensen; Mark S Carey; Philip Beale; Andrés Cervantes; Christian Kurzeder; Andreas du Bois; Jalid Sehouli; Rainer Kimmig; Anne Stähle; Fiona Collinson; Sharadah Essapen; Charlie Gourley; Alain Lortholary; Frédéric Selle; Mansoor R Mirza; Arto Leminen; Marie Plante; Dan Stark; Wendi Qian; Mahesh K B Parmar; Amit M Oza
Journal:  N Engl J Med       Date:  2011-12-29       Impact factor: 91.245

5.  Incorporation of bevacizumab in the primary treatment of ovarian cancer.

Authors:  Robert A Burger; Mark F Brady; Michael A Bookman; Gini F Fleming; Bradley J Monk; Helen Huang; Robert S Mannel; Howard D Homesley; Jeffrey Fowler; Benjamin E Greer; Matthew Boente; Michael J Birrer; Sharon X Liang
Journal:  N Engl J Med       Date:  2011-12-29       Impact factor: 91.245

6.  Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.

Authors:  Irène Asmane; Jean-Emmanuel Kurtz; Agathe Bajard; Jean-Paul Guastalla; Pierre Meeus; Olivier Tredan; Intidhar Labidi Galy; Isabelle Moullet; Philippe Ardisson; Lionel Vincent; David Coeffic; Armelle Dufresne; Jean-Pierre Bergerat; Isabelle Ray-Coquard
Journal:  Bull Cancer       Date:  2011-10       Impact factor: 1.276

7.  A case of dermoid cyst of the ovary with malignant transformation complicated with small intestinal fistula formation.

Authors:  Susumu Okada; Yoshiharu Ohaki; Kohei Inoue; Hidenobu Nakajo; Hiroshi Kawamata; Tatsuo Kumazaki
Journal:  Radiat Med       Date:  2005-09

8.  Chemotherapy in the management of advanced gastointestinal non-Hodgkin's lymphoma complicated with entero-cutaneous fistula: a case report.

Authors:  A Adenipekun; A Abudus-Salam; T N Elumele
Journal:  Afr J Med Med Sci       Date:  2005-06

9.  Successful closure of anal cancer-related fistulas with upfront intra-arterial chemotherapy: a report of 8 cases.

Authors:  Robert Kridel; Stéphane Cochet; Bruno Roche; Albéric Bressoud; Pascal Gervaz; Michael Betz; Arnaud D Roth
Journal:  Dis Colon Rectum       Date:  2011-05       Impact factor: 4.585

10.  The risk of gastrointestinal perforation and/or fistula in patients with recurrent ovarian cancer receiving bevacizumab compared to standard chemotherapy: a retrospective cohort study.

Authors:  Gregory P Sfakianos; T Michael Numnum; Caitlin B Halverson; Deepa Panjeti; James E Kendrick; J Michael Straughn
Journal:  Gynecol Oncol       Date:  2009-06-23       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.